George Soros Boosts Stake in NPS Pharmaceuticals to 7.1 Percent
NEW YORK -- Billionaire financier George Soros has boosted his stake in drug developer NPS Pharmaceuticals Inc. to 7.1 percent from 6.8 percent, according to filings made with regulators Wednesday.
Soros controls almost 3.3 million of the company's shares through Quantum Partners LDC, an affiliate of Soros Fund Management LLC, according to the filing with the Securities and Exchange Commission. It's an increase from the 3.1 million shares he said he controlled as of May 17, according to previous filings.
Shares of Salt Lake City-based NPS Pharmaceuticals hit a 52-week low of $4.52 last week, after the company announced a restructuring plan that included cutting half its staff.
Shares of the company rose 15 cents, or 3.1 percent, to $4.95 in after-hours trading on the INET electronic exchange. They closed down 2 cents at $4.80 on the Nasdaq.
NEW YORK -- Billionaire financier George Soros has boosted his stake in drug developer NPS Pharmaceuticals Inc. to 7.1 percent from 6.8 percent, according to filings made with regulators Wednesday.
Soros controls almost 3.3 million of the company's shares through Quantum Partners LDC, an affiliate of Soros Fund Management LLC, according to the filing with the Securities and Exchange Commission. It's an increase from the 3.1 million shares he said he controlled as of May 17, according to previous filings.
Shares of Salt Lake City-based NPS Pharmaceuticals hit a 52-week low of $4.52 last week, after the company announced a restructuring plan that included cutting half its staff.
Shares of the company rose 15 cents, or 3.1 percent, to $4.95 in after-hours trading on the INET electronic exchange. They closed down 2 cents at $4.80 on the Nasdaq.
posted by doublezero at
6:12 PM
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home